Prof. Bukreyev has completed his PhD in 1993 and completed his postdoctoral studies at the National Institute of Allergy and Infectious Diseases, NIH. He is professor at the University of Texas Medical Branch at Galveston. His laboratory focuses on development of vaccines against highly pathogenic viruses filoviruses Ebola and Marburg and on investigation of mechanisms of their high pathogenicity. He has published more about 90 papers in reputed journals including Science, Cell, Journal of Clinical Investigation, PNAS, PLOS Pathogens, The Lancet, Journal of Virology, Vaccine and others. He is a member of NIH Vaccines Against Microbial Diseases Study Section. Prof. Bukreyev has completed his PhD in 1993 and completed his postdoctoral studies at the National Institute of Allergy and Infectious Diseases, NIH. He is professor at the University of Texas Medical Branch at Galveston. His laboratory focuses on development of vaccines against highly pathogenic viruses filoviruses Ebola and Marburg and on investigation of mechanisms of their high pathogenicity. He has published more about 90 papers in reputed journals including Science, Cell, Journal of Clinical Investigation, PNAS, PLOS Pathogens, The Lancet, Journal of Virology, Vaccine and others. He is a member of NIH Vaccines Against Microbial Diseases Study Section.

Vaccines, Immunology